Fig. 4.
Survival curves for tamoxifen-treated patients, grouped according to tumoral CXCL10 expression in terms of local recurrence-free survival. All patient tumors are estrogen receptor positive. a Patients with moderate/high tumoral CXCL10 expression and b patients with no/low tumoral CXCL10 expression